步长制药: 山东步长制药股份有限公司第五届董事会第三十次会议决议公告

Core Points - The company held its 30th meeting of the 5th Board of Directors on August 27, 2025, with all 9 attending directors voting unanimously on several proposals [1][2][3][4][5] - The company approved the special report on the storage and actual use of raised funds for the first half of 2025, which complies with relevant laws and regulations [2][3] - A profit distribution plan for the first half of 2025 was proposed to enhance investor returns and boost shareholder confidence, which does not require shareholder meeting approval [3][4] - The company developed an action plan for 2025 aimed at improving quality and efficiency, in response to national policies and stock exchange initiatives [4][5] - The company conducted a mid-year evaluation of the 2024 action plan focused on quality improvement and return enhancement, with results disclosed in a report [5]